The crosstalk between m6A RNA methylation and other epigenetic regulators: a novel perspective in epigenetic remodeling

被引:70
|
作者
Zhao, Yanchun [1 ]
Chen, Yunhao [2 ]
Jin, Mei [1 ]
Wang, Jin [1 ]
机构
[1] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Pathol, Hangzhou 310000, Peoples R China
[2] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Surg,Div Hepatobiliary & Pancreat Surg, Hangzhou 310000, Peoples R China
来源
THERANOSTICS | 2021年 / 11卷 / 09期
关键词
N-6-methyladenosine (m(6)A); DNA methylation; chromatin remodeling; histone modification; non-coding RNA (ncRNA); RNA modification; METHYLTRANSFERASE METTL3 PROMOTES; MESSENGER-RNA; NONCODING RNA; NUCLEAR-RNA; M(6)A METHYLTRANSFERASE; COLORECTAL-CANCER; N-6-METHYLADENOSINE MODIFICATION; UNIQUE FEATURES; GENE-EXPRESSION; CIRCULAR RNAS;
D O I
10.7150/thno.54967
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Epigenetic regulation involves a range of sophisticated processes which contribute to heritable alterations in gene expression without altering DNA sequence. Regulatory events predominantly include DNA methylation, chromatin remodeling, histone modifications, non-coding RNAs (ncRNAs), and RNA modification. As the most prevalent RNA modification in eukaryotic cells, N-6-methyladenosine (m(6)A) RNA methylation actively participates in the modulation of RNA metabolism. Notably, accumulating evidence has revealed complicated interrelations occurring between m(6)A and other well-known epigenetic modifications. Their crosstalk conspicuously triggers epigenetic remodeling, further yielding profound impacts on a variety of physiological and pathological processes, especially tumorigenesis. Herein, we provide an up-to-date review of this emerging hot area of biological research, summarizing the interplay between m(6)A RNA methylation and other epigenetic regulators, and highlighting their underlying functions in epigenetic reprogramming.
引用
收藏
页码:4549 / 4566
页数:18
相关论文
共 50 条
  • [1] Exploration of m6A methylation regulators as epigenetic targets for immunotherapy in advanced sepsis
    Weiwei Qian
    Jian Zhou
    Songtao Shou
    BMC Bioinformatics, 24
  • [2] Exploration of m6A methylation regulators as epigenetic targets for immunotherapy in advanced sepsis
    Qian, Weiwei
    Zhou, Jian
    Shou, Songtao
    BMC BIOINFORMATICS, 2023, 24 (01)
  • [3] m6A epitranscriptomic and epigenetic crosstalk in cardiac fibrosis
    Liu, Zhi-Yan
    Lin, Li-Chan
    Liu, Zhen-Yu
    Yang, Jing-Jing
    Tao, Hui
    MOLECULAR THERAPY, 2024, 32 (04) : 878 - 889
  • [4] Crosstalk Between Histone and m6A Modifications and Emerging Roles of m6A RNA Methylation
    Xu, Zibin
    Xie, Tingfei
    Sui, Xiaolu
    Xu, Yunpeng
    Ji, Lecai
    Zhang, Yanzi
    Zhang, Aisha
    Chen, Jihong
    FRONTIERS IN GENETICS, 2022, 13
  • [5] m6A RNA methylation and beyond - The epigenetic machinery and potential treatment options
    Garbo, Sabrina
    Zwergel, Clemens
    Battistelli, Cecilia
    DRUG DISCOVERY TODAY, 2021, 26 (11) : 2559 - 2574
  • [6] RNA m6A methylation regulators in sepsis
    Zhu, Lin
    Zhang, Hairong
    Zhang, Xiaoyu
    Xia, Lei
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2024, 479 (09) : 2165 - 2180
  • [7] Epigenetic role ofN6-methyladenosine (m6A) RNA methylation in the cardiovascular system
    Zhao, Kun
    Yang, Chuan-xi
    Li, Peng
    Sun, Wei
    Kong, Xiang-qing
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2020, 21 (07): : 509 - 523
  • [8] RNA m6A methylation regulators in ovarian cancer
    Jialu Guo
    Jianfeng Zheng
    Huizhi Zhang
    Jinyi Tong
    Cancer Cell International, 21
  • [9] RNA m6A methylation regulators in ovarian cancer
    Guo, Jialu
    Zheng, Jianfeng
    Zhang, Huizhi
    Tong, Jinyi
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [10] RNA m6A methylation regulators in liver cancer
    Qiaoping Xu
    Ning Ren
    Lanqi Ren
    Yibei Yang
    Junjie Pan
    Hongkai Shang
    Cancer Cell International, 24